# Study to Evaluate Safety, Efficacy and Tolerability of Clobetasol Propionate for Chronic Hand Dermatitis

> **NCT00828464** · PHASE4 · COMPLETED · sponsor: **Stiefel, a GSK Company** · enrollment: 30 (actual)

## Conditions studied

- Hand Dermatosis

## Interventions

- **DRUG:** clobetasol propionate

## Key facts

- **NCT ID:** NCT00828464
- **Lead sponsor:** Stiefel, a GSK Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2009-01
- **Final completion:** 2009-01
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2012-10-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00828464

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00828464, "Study to Evaluate Safety, Efficacy and Tolerability of Clobetasol Propionate for Chronic Hand Dermatitis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00828464. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*